Fertility treatment is pursued by a minority of the 1 in 6 adults globally affected by infertility. Cusatis et al.’s 2023 longitudinal cohort study of infertile couples (n=120 at 6-year follow-up, PMC10633954) found that approximately 1 in 5 women (19%) across all groups expressed moderate-to-severe regret, cohort-wide. That cohort-wide figure blends very different outcomes, though: women who succeeded at treatment showed near-zero regret, while those who did not add a child (regardless of treatment path) showed the highest scores overall.
The clinical context shapes the decision considerably. Fertility treatment ranges from low-intervention options such as clomiphene or intrauterine insemination to high-cost, high-intensity IVF cycles and donor procedures, but the regret data do not track that intensity gradient the way it might seem: Cusatis et al. found identical median regret scores (0) for the IVF group and the other, lower-intensity treatment group, with failing to add a child at all as the sharpest divide (median 35). Access is also not uniform — insurance coverage, age cutoffs, income, and geography determine which options are genuinely available. The WHO estimates roughly 1 in 6 people worldwide (17.5% of the adult population) are affected by infertility, with comparable lifetime prevalence across high-, middle-, and low-income countries, but treatment access is concentrated in high-income settings.








